Richardson P, Mitsiades C, Laubach J, Conant C, Hideshima T, Chauhan D, Schlossman R, Ghobrial I, Munshi N, Anderson K. Proteasome inhibitors: beyond NFKB inhibition alone and the emerging role of combination therapy in the treatment of multiple myeloma. Hematol Meeting Rep [Internet]. 2009 Jun. 23 [cited 2024 Nov. 22];2(5). Available from: https://www.pagepress.org/journals/hmr/article/view/753